Drug Trial Radar · NCT06294990
Klinefelter Syndrome and Testosterone Treatment in Puberty
Last checked: Nov 20, 2026Latest source record: Feb 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
32
Planned (sponsor's estimate)
Start
Aug 15, 2024
Primary completion
Dec 31, 2029
Study completion Dec 31, 2029
Sponsor
- Lead sponsor
- Lise AksglædeAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 6, 2024
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 10 years, up to 14 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this randomized clinical trial is to study the effect of testosterone replacement therapy during puberty in boys with Klinefelter syndrome (KS, 47,XXY). The main questions to answer are how treatment with testosterone will affect body fat mass, lipid and glucose metabolism, growth and body proportions, bone mineralization as well as effects on neurocognitive development and emotional and social difficulties. Participants will be randomized to two years treatment with testosterone or placebo.
Conditions
- Klinefelter Syndrome
Interventions
Testosterone gelDrug
Two years treatment with testosterone
PlaceboOther
Two years treatment with placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes in body fat massTime frame: Baseline and 1 and two years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Copenhagen University Hospital, Rigshospitalet
Copenhagen, Denmark · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.